Products and supplies for managing diabetes: blood glucose meters, test strips and lancets, insulin pens and pumps, continuous glucose monitors, insulin storage and delivery accessories, diabetic wound and foot care items, nutrition and supplements, plus information on safe use and monitoring.
Products and supplies for managing diabetes: blood glucose meters, test strips and lancets, insulin pens and pumps, continuous glucose monitors, insulin storage and delivery accessories, diabetic wound and foot care items, nutrition and supplements, plus information on safe use and monitoring.
Medications in the Diabetes category are treatments used to help manage blood glucose levels and the metabolic effects of diabetes mellitus. They include a range of oral tablets and some newer non-insulin injectable or oral incretin therapies that act through different physiological mechanisms. While many products in this category target type 2 diabetes, some medicines are used as part of broader treatment plans that address the varied needs of people with diabetes. The overall aim of these medicines is to improve glycemic control and reduce the risk of complications associated with prolonged high blood sugar.
These medicines are commonly used to lower fasting and post-meal blood glucose, reduce long-term markers such as HbA1c, and complement lifestyle measures like diet and physical activity. In practice they may be prescribed as initial therapy, added to other agents when single-drug therapy is insufficient, or combined into fixed-dose products that simplify dosing. Some drugs act quickly to control spikes after meals, while others provide ongoing background glucose-lowering effects; different choices reflect how a person’s blood glucose varies over the day and over longer periods.
The category contains several major classes of oral agents and combination products. Biguanides are represented by metformin formulations such as Glucophage, Glucophage SR/XR and Glycomet, which lower liver glucose production and improve insulin sensitivity. Sulfonylureas and related insulin secretagogues include medicines like Glucotrol, Glucotrol XL, Micronase and Amaryl that stimulate insulin release. Other classes present here include thiazolidinediones (for example Actos and combination products like Actoplus met), meglitinides such as Prandin, alpha-glucosidase inhibitors like Precose, fixed combinations such as Glucovance and Jentadueto XR, and newer incretin-based therapies exemplified by Rybelsus. Immediate-release and extended-release formulations are both available for several agents to accommodate different dosing needs.
Safety profiles and potential side effects vary by class. Gastrointestinal symptoms are commonly reported with metformin and some other agents, while drugs that increase insulin release can raise the risk of low blood sugar under certain conditions. Some medicines may affect body weight, fluid balance, or the function of organs such as the liver and kidneys, and interactions with other medications are possible. Many products are prescription-only and routinely require periodic monitoring, including checks on blood glucose control and relevant laboratory tests, to ensure safe and effective use.
When people shop within this category they typically compare factors such as how a medicine fits into a daily routine (dosing frequency and whether it is immediate or extended release), its route of administration, expected effects on HbA1c and daily glucose patterns, and the known side effect profile. Others consider formulation options, whether a product is available as a combination tablet, storage requirements, coverage by health plans, and whether the pharmacologic action complements other treatments they are using. Clear information about active ingredients and formulation helps consumers match options to practical needs while healthcare professionals determine clinical appropriateness.
— 